Vanda Pharmaceuticals Inc (NASDAQ: VNDA): What’s Next After The Stock Plunge?

The trading price of Vanda Pharmaceuticals Inc (NASDAQ:VNDA) closed higher on Friday, May 10, closing at $5.04, 0.60% higher than its previous close.

In examining the 52-week price action we see that the stock hit a 52-week high of $6.92 and a 52-week low of $3.30. Over the past month, the stock has gained 17.76% in value.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Vanda Pharmaceuticals Inc, whose market valuation is $293.33 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable.

On the technical side, indicators suggest VNDA has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 50% Buy.

A quick review shows that VNDA’s price is currently 5.84% off the SMA20 and 15.20% off the SMA50. The RSI metric on the 14-day chart is currently showing 56.35, and weekly volatility stands at 7.93%. When measured over the past 30 days, the indicator reaches 5.82%. Vanda Pharmaceuticals Inc (NASDAQ:VNDA)’s beta value is currently sitting at 0.70, while the Average True Range indicator is currently displaying 0.34.

To see how Vanda Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: VNDA stock’s performance was 0.60% in the latest trading, and -25.66% in the past year.

An evaluation of the daily trading volume of Vanda Pharmaceuticals Inc (NASDAQ:VNDA) indicates that the 3-month average is 2.43 million.

Currently, records show that 57.53 million of the company’s shares remain outstanding. The insiders hold 5.26% of outstanding shares, whereas institutions hold 85.86%. However, since the stock’s price has seen 19.43% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.

Most Popular